Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boehringer Ingelheim Austria GmbH

Division of Boehringer Ingelheim International GmbH
www.boehringer-ingelheim.at

Latest From Boehringer Ingelheim Austria GmbH

Avidia Research Institute Inc.

Avidia Research Institute Inc. has identified an undisclosed naturally occurring family of proteins that act like antibodies by binding to ligands, yet are genetically distinct. The company's Maxybodies hold promise for overcoming most of the pharmacologic drawbacks of antibody drugs, while eliminating the IP royalty stack.
See All
Advertisement
Advertisement
UsernamePublicRestriction

Register